Manonthestreet
Diamond Member
- May 20, 2014
- 37,578
- 27,543
- 2,945
An experimental pill has achieved the complete remission of cancer in 18 near-terminal patients with aggressive tumors that did not respond to treatments. The illness, acute myeloid leukemia, is the most common blood cancer in adults, accounting for 120,000 cases each year. The three-year survival rate is just 25%. The new drug, called revumenib, has completely eliminated cancer in a third of the participants in a long-awaited clinical study in the United States. Experimental pill achieves complete cancer remission in 18 people with aggressive leukemia
PAss it along if you know anyone suffering from this...
PAss it along if you know anyone suffering from this...